ARAB HEALTH 2023 16 COMPANY PROFILE Xepa is a leading pharmaceutical company in Malaysia focusing on premium off-patent pharmaceutical products. Founded in 1967 in Singapore and now based in 10 acres site in Melaka, Malaysia, Xepa has established a track record of producing high quality and affordable medicines that have grown to be trusted by generations of our customer. We formulate and manufacture wide range of products, including tablets, capsules, powders, oral liquids, cream, ointment, and sterile eye drops. We are the leading R&D and producer of respiratory, cough & cold and cardiovascular drugs in Malaysia. Xepa’s products are widely used in private and public sectors, and also exported to 16 countries around the world such us Hong Kong, Singapore, Japan, Taiwan and countries in Africa and the ASEAN region. Xepa was awarded the EU Good Manufacturing Practices certification in 2017. Xepa was certified meeting the EN ISO 13485:2016 accreditation for the Design and Development, Manufacture and Distribution of Sterile Eye Drops, in 2019. Good Distribution Practices for Medical Devices [GDPMD] was secured from Medical Devices Agency in 2020. In the same year, Xepa secured GMP clearance from the Australia TGA for non-sterile dosage forms.
RkJQdWJsaXNoZXIy NjUyODU0